Curebase is the modern eClinical platform for faster study builds, better engagement, and seamless data capture.
Curebase has raised $40.0M in total funding. The most recent round was Series B. The last funding was announced in May 2022.
Curebase's investors include Y Combinator, Gaingels, Notable Capital, Future Planet Capital, Pioneer Fund.
Curebase is headquartered in San Francisco, United States.
Curebase is the modern eClinical platform for faster study builds, better engagement, and seamless data capture.
Curebase is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Curebase — Funding & Investors." VCBacked, May 5, 2022, https://www.vcbacked.co/company/curebase. Accessed September 3, 2026.
VCBacked. (2022). Curebase — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/curebase
{{cite web |title=Curebase — Funding & Investors |url=https://www.vcbacked.co/company/curebase |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated